Northern Trust Corp Applied Molecular Transport Inc. Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.32 - $0.68 $2,110 - $4,484	-6,595 Reduced 14.57%	38,666 $12,000
Q4 2022 Feb 13, 2023	SELL	$0.35 - $1.26 $2,100 - $7,560	-6,000 Reduced 11.7%	45,261 $19,000
Q3 2022 Nov 14, 2022	SELL	$1.12 - $3.12 $112 - $312	-100 Reduced 0.19%	51,261 $50,000
Q2 2022 Aug 12, 2022	SELL	$2.76 - $7.65 $507,125 - $1.41 Million	-183,741 Reduced 78.15%	51,361 $150,000
Q1 2022 May 13, 2022	SELL	$5.63 - $13.88 $15,628 - $38,530	-2,776 Reduced 1.17%	235,102 $1.77 Million
Q4 2021 Feb 08, 2022	SELL	$13.23 - $26.05 $43,209 - $85,079	-3,266 Reduced 1.35%	237,878 $3.33 Million
Q3 2021 Nov 15, 2021	SELL	$25.87 - $46.61 $298,462 - $537,739	-11,537 Reduced 4.57%	241,144 $6.24 Million
Q2 2021 Aug 13, 2021	BUY	$39.76 - $64.31 $681,208 - $1.1 Million	17,133 Added 7.27%	252,681 $11.6 Million
Q1 2021 May 12, 2021	BUY	$30.5 - $74.14 $1.69 Million - $4.11 Million	55,503 Added 30.83%	235,548 $10.4 Million
Q4 2020 Feb 11, 2021	SELL	$29.39 - $35.0 $104,981 - $125,020	-3,572 Reduced 1.95%	180,045 $5.54 Million
Q3 2020 Nov 16, 2020	BUY	$20.49 - $33.58 $3.76 Million - $6.17 Million	183,617 New	183,617 $5.84 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.